Reference
FDA. Pradaxa (dabigatran): Drug Safety Communication - Lower Risk for Stroke and Death, but Higher Risk for GI Bleeding Compared to Warfarin. Internet Document : 14 May 2014. Available from: URL: http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm397179.htm
Rights and permissions
About this article
Cite this article
FDA reveals new safety data on dabigatran. Reactions Weekly 1502, 2 (2014). https://doi.org/10.1007/s40278-014-0873-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-014-0873-y